Anthelmintic efficacy on UK Thoroughbred stud farms.
Valerie E Relf1, Hannah E Lester1, Eric R Morgan2
1Moredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, UK.
International Journal for Parasitology
|April 22, 2014
Summary
Widespread use of anthelmintic drugs in horses has led to reduced efficacy. Moxidectin and ivermectin showed acceptable efficacy against strongyles initially, but shortened egg reappearance periods indicate emerging resistance.
Area of Science:
- Veterinary Parasitology
- Equine Health
- Anthelmintic Resistance
Background:
- Anthelmintic drugs have been used for over 40 years to control horse nematodes.
- Indiscriminate use may lead to reduced drug efficacy and resistance.
Purpose of the Study:
- To investigate the efficacy of four broad-spectrum anthelmintic drugs against horse nematodes.
- To assess potential emerging anthelmintic resistance in Thoroughbred stud farms.
Main Methods:
- Faecal egg count reduction tests (FECRT) were conducted on 16 Thoroughbred farms.
- 429 horses were treated with ivermectin, moxidectin, pyrantel, or fenbendazole.
- Egg reappearance periods (ERP) were monitored for up to 12 weeks post-treatment.
Main Results:
- Moxidectin was highly efficacious against strongyles (99.8-100% reduction).
- Reduced efficacy of pyrantel was observed in yearlings (0-73% reduction), but not in mares (98-99.4% reduction).
- Fenbendazole showed consistently low efficacy (0.4-41% reduction).
- Ivermectin efficacy varied (85.7-100% reduction), with reduced efficacy in one yearling group.
- Efficacy against Parascaris equorum varied, with fenbendazole showing acceptable results (97.5-99.9%) but ivermectin reduced efficacy (25.5-91.2%).
- ERP for moxidectin, ivermectin, and pyrantel were shorter than previously recorded.
Conclusions:
- Moxidectin and ivermectin demonstrated acceptable efficacy at 14 days post-treatment.
- Shortened ERP suggest reduced effectiveness and impending multi-drug resistance in strongyles.
- Strategic anthelmintic drug use is crucial to mitigate resistance development.


